Diagnosis and Treatment of Renal Cell Carcinoma During Pregnancy

Renal cell carcinoma during pregnancy is extremely rare, but it is the commonest urological malignancy reported in pregnancy. Currently, no uniform domestic or international diagnostic or treatment criteria exist for these patients, so their diagnosis and treatment are challenging for urologists. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Hainan, Tan, Shutao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721013/
https://www.ncbi.nlm.nih.gov/pubmed/35002320
http://dx.doi.org/10.2147/CMAR.S345309
_version_ 1784625247427756032
author Xu, Hainan
Tan, Shutao
author_facet Xu, Hainan
Tan, Shutao
author_sort Xu, Hainan
collection PubMed
description Renal cell carcinoma during pregnancy is extremely rare, but it is the commonest urological malignancy reported in pregnancy. Currently, no uniform domestic or international diagnostic or treatment criteria exist for these patients, so their diagnosis and treatment are challenging for urologists. The health and reproductive needs of these patients have improved in recent years because of the continuous development of medical technology. This article reviews the epidemiology, risk factors, diagnosis, treatment, and prognosis of renal cell carcinoma during pregnancy.
format Online
Article
Text
id pubmed-8721013
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-87210132022-01-06 Diagnosis and Treatment of Renal Cell Carcinoma During Pregnancy Xu, Hainan Tan, Shutao Cancer Manag Res Review Renal cell carcinoma during pregnancy is extremely rare, but it is the commonest urological malignancy reported in pregnancy. Currently, no uniform domestic or international diagnostic or treatment criteria exist for these patients, so their diagnosis and treatment are challenging for urologists. The health and reproductive needs of these patients have improved in recent years because of the continuous development of medical technology. This article reviews the epidemiology, risk factors, diagnosis, treatment, and prognosis of renal cell carcinoma during pregnancy. Dove 2021-12-29 /pmc/articles/PMC8721013/ /pubmed/35002320 http://dx.doi.org/10.2147/CMAR.S345309 Text en © 2021 Xu and Tan. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Xu, Hainan
Tan, Shutao
Diagnosis and Treatment of Renal Cell Carcinoma During Pregnancy
title Diagnosis and Treatment of Renal Cell Carcinoma During Pregnancy
title_full Diagnosis and Treatment of Renal Cell Carcinoma During Pregnancy
title_fullStr Diagnosis and Treatment of Renal Cell Carcinoma During Pregnancy
title_full_unstemmed Diagnosis and Treatment of Renal Cell Carcinoma During Pregnancy
title_short Diagnosis and Treatment of Renal Cell Carcinoma During Pregnancy
title_sort diagnosis and treatment of renal cell carcinoma during pregnancy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721013/
https://www.ncbi.nlm.nih.gov/pubmed/35002320
http://dx.doi.org/10.2147/CMAR.S345309
work_keys_str_mv AT xuhainan diagnosisandtreatmentofrenalcellcarcinomaduringpregnancy
AT tanshutao diagnosisandtreatmentofrenalcellcarcinomaduringpregnancy

Ejemplares similares